NO861577L - Antigen, antistoff og fremgangsmaate for dets fremstilling og anvendelse derav for diagnostisering. - Google Patents

Antigen, antistoff og fremgangsmaate for dets fremstilling og anvendelse derav for diagnostisering.

Info

Publication number
NO861577L
NO861577L NO861577A NO861577A NO861577L NO 861577 L NO861577 L NO 861577L NO 861577 A NO861577 A NO 861577A NO 861577 A NO861577 A NO 861577A NO 861577 L NO861577 L NO 861577L
Authority
NO
Norway
Prior art keywords
antigen
antibody
diagnosis
procedure
manufacturing
Prior art date
Application number
NO861577A
Other languages
English (en)
Other versions
NO170810C (no
NO170810B (no
Inventor
Lana Grauer
Joy Koda
Julia Leung
Original Assignee
Hybritech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hybritech Inc filed Critical Hybritech Inc
Publication of NO861577L publication Critical patent/NO861577L/no
Publication of NO170810B publication Critical patent/NO170810B/no
Publication of NO170810C publication Critical patent/NO170810C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1063—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell being from stomach or intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Optics & Photonics (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO861577A 1985-04-22 1986-04-22 Monoklonalt antistoff av igm-klassen for bruk in vitro ogfremgangsmaate for in vitro deteksjon og diagnose av cancer eller cystisk fibrose NO170810C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72620285A 1985-04-22 1985-04-22

Publications (3)

Publication Number Publication Date
NO861577L true NO861577L (no) 1986-10-23
NO170810B NO170810B (no) 1992-08-31
NO170810C NO170810C (no) 1992-12-09

Family

ID=24917624

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861577A NO170810C (no) 1985-04-22 1986-04-22 Monoklonalt antistoff av igm-klassen for bruk in vitro ogfremgangsmaate for in vitro deteksjon og diagnose av cancer eller cystisk fibrose

Country Status (9)

Country Link
EP (1) EP0200464B1 (no)
JP (1) JPS61289897A (no)
AT (1) ATE79632T1 (no)
AU (2) AU599589B2 (no)
DE (1) DE3686438T2 (no)
DK (1) DK185086A (no)
ES (2) ES8800604A1 (no)
FI (1) FI87141C (no)
NO (1) NO170810C (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU613590B2 (en) * 1986-11-19 1991-08-08 Bristol-Myers Squibb Company Hybridomas producing monoclonal antibodies to new mucin epitopes
US6004761A (en) * 1986-11-19 1999-12-21 Sanofi Method for detecting cancer using monoclonal antibodies to new mucin epitopes
JPS63157995A (ja) * 1986-12-18 1988-06-30 Kyowa Hakko Kogyo Co Ltd 抗ヒト大腸癌単クロ−ン性抗体ａｃｃ−５７４
DK169987D0 (da) * 1987-04-03 1987-04-03 Jens Christian Jensenius Human tumor-associated antigen, ca-ou1
JP2688824B2 (ja) * 1987-05-29 1997-12-10 郁男 山科 単クローン抗体ｎｋｙ１３
US5073493A (en) * 1987-05-29 1991-12-17 Ikuo Yamashina Monoclonal antibody nky13
ATE137674T1 (de) * 1987-07-02 1996-05-15 Akzo Nobel Nv Von mca 16-88 erkanntes antigen
EP0397419A3 (en) * 1989-05-10 1991-04-03 Hybritech Incorporated Novel tumor-associated antigen, antibodies, compositions and uses therefor
EP0491867B1 (en) * 1989-09-15 1996-11-27 Genetic Systems Corporation Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer
IT1262954B (it) * 1992-07-03 1996-07-23 Ist Farmacoterapico It Spa Regioni antigeniche dei complessi tpl e anticorpi diretti contro di essi.
AU2001252945A1 (en) * 2000-03-24 2001-10-08 Corixa Corporation Compositions and methods for therapy and diagnosis of colon cancer
US20120021444A1 (en) * 2008-12-18 2012-01-26 Eidia Co., Ltd. Method for diagnosis of cystic fibrosis using kl-6 levels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468457A (en) * 1981-06-01 1984-08-28 David M. Goldenberg Method for producing a CSAp tryptic peptide and anti-CSAp antibodies
NZ212419A (en) * 1984-06-25 1988-08-30 Mucan Diagnostics Pty Ltd In vitro diagnostic test for detecting cancer cells producing mucin antigens
DK172686A (da) * 1985-04-22 1986-10-23 Hybritech Inc Antigen opnaaet ud fra humant vaev, fremgangsmaade til under anvendelse af antigenet at fremstille monoklonale antistoffer til diagnose og behandling af cancer, fremgangsmaade til paavisning af cancer, samt antistoffer mod antigenet

Also Published As

Publication number Publication date
NO170810C (no) 1992-12-09
JPS61289897A (ja) 1986-12-19
FI861692A0 (fi) 1986-04-22
FI87141C (fi) 1992-12-10
ES8900247A1 (es) 1989-05-16
ES554209A0 (es) 1987-11-16
AU5646986A (en) 1987-10-29
AU599589B2 (en) 1990-07-26
FI861692L (fi) 1986-10-23
DK185086A (da) 1986-10-23
ATE79632T1 (de) 1992-09-15
DE3686438D1 (de) 1992-09-24
AU627084B2 (en) 1992-08-13
AU6556990A (en) 1991-01-17
ES8800604A1 (es) 1987-11-16
DK185086D0 (da) 1986-04-22
DE3686438T2 (de) 1993-01-21
EP0200464A3 (en) 1988-05-04
NO170810B (no) 1992-08-31
FI87141B (fi) 1992-08-31
EP0200464B1 (en) 1992-08-19
ES557680A0 (es) 1989-05-16
EP0200464A2 (en) 1986-11-05

Similar Documents

Publication Publication Date Title
ATE117370T1 (de) Chimärer antikörper mit spezifität für menschliches tumor-antigen.
ATE56046T1 (de) Monoklonale antikoerper gegen humane brustkarzinomzellen und ihre verwendung in der diagnose und therapie.
DE3852054D1 (de) Monoklonale Antikörper gegen Glycolipid-Antigene und ihre Verwendung.
NO861577L (no) Antigen, antistoff og fremgangsmaate for dets fremstilling og anvendelse derav for diagnostisering.
ES8800603A1 (es) Un metodo para producir anticuerpos monoclonales
EP0380607A4 (en) Anti-idiotype antibodies to anti-human high molecular weight-melanoma associated antigen
JPS6461499A (en) Monoclonal antibody to human papilloma viruses 16 type e7 protein, and production and use thereof
ATE86261T1 (de) Tumorassoziiertes antigen.
DE3885975D1 (de) Monoklonale Antikörper gegen menschliche alpha-Atrialnatriüretic-Polypeptide und entsprechende Hybridome, deren Herstellung und Verwendung.
ATE92081T1 (de) Tumorassoziiertes antigen.
EP0397419A3 (en) Novel tumor-associated antigen, antibodies, compositions and uses therefor
GR890100333A (en) Antihuman antigen antibodies
EP0332421A3 (en) Monoclonal antibodies recognizing human psti, hybridomas producing the same, and their preparation and use